Valencell develops and delivers innovative, medical-grade digital health solutions focused on chronic disease management. Our intuitive, accurate solutions make it easier for consumers to manage their own health. Valencell’s patented biometric sensor technology, proprietary algorithms, and analytics, used by third-party wearable solutions on the market today, have been clinically validated in thousands of diverse participants over many years. Founded: Founded in 2006 and headquartered in Raleigh, North Carolina Investors: Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund Leadership Kent Novak, Chairman, CEO Steven LeBoeuf, Ph.D., Founder & President Michael Aumer, Ph.D., VP of R&D Kristine O'Shea, VP of Finance Mark Felice, VP of Business Development and Licensing Rebecca Cook, VP of Marketing 4601 Six Forks Road Suite 103 Raleigh, NC 27609 919-747-3668 / info@valencell.com / www.valencell.com